Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells
European Journal of Gastroenterology and Hepatology, Volume 23, No. 10, Year 2011
Notification
URL copied to clipboard!
Description
AIM: One of the defining features of the liver is the capacity to maintain a constant size despite injury. Extrahepatic stem cells especially bone marrow-derived stem cells are thought to undertake an important role in liver repopulation. This study was carried out to evaluate the outcome of autologous bone marrow-derived hepatocytes transplantation in patients with end-stage liver cell failure due to chronic hepatitis C. METHODS: Forty patients were included, divided into two groups. Group I: 20 patients receiving autologous bone marrow-derived mesenchymal stem cells stimulated to hepatic lineage. They were subdivided into two groups regarding the route of transplantation: intrasplenic (10) and intrahepatic (10). Group II: included 20 patients who received traditional supportive treatment. Patients were followed up using examination, laboratory investigations, abdominal ultrasonography, and evaluated by Child score, Model for End Stage Liver Disease score, fatigue scale, and performance status. RESULTS: The results showed significant improvement in group I regarding ascites, lower limb edema, and serum albumin, over the control group. Group I also showed statistically significant improvement in Child score, Model for End Stage Liver Disease score, fatigue scale, and performance status over the controls. No difference was observed between intrahepatic and intrasplenic groups. CONCLUSION: This study demonstrated the safety and short-term efficacy of autologous bone marrow-derived mesenchymal stem cell injection in liver cell failure. Further study is necessary to standardize the cell dose, determine the life span of the injected cells, and detect the appearance of long-term complications. © 2011 Wolters Kluwer Health | Lippincott Williams &Wilkins.
Authors & Co-Authors
Amer, Mohie Eldeen M.
Egypt, Cairo
Al-azhar University
Zaky, Samy
Egypt, Cairo
Al-azhar University
El-Kheir, Wael Abo
Egypt, Cairo
Military Medical Academy
Gabr, Hala M.
Egypt, Giza
Cairo University
Gomaa, Ahmed Ali
Egypt, Cairo
Al-azhar University
El-Noomani, Nabil
Egypt, Cairo
Al-azhar University
Hegazy, Mohamed
Egypt, Cairo
Al-azhar University
Statistics
Citations: 144
Authors: 7
Affiliations: 3
Identifiers
Doi:
10.1097/MEG.0b013e3283488b00
ISSN:
0954691X
e-ISSN:
14735687
Research Areas
Cancer
Infectious Diseases
Maternal And Child Health
Violence And Injury
Study Design
Randomised Control Trial